SEI Investments’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

SEI Investments’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-12,651	Closed	-$249K	–	2766
2022 Q1	$249K	Buy	12,651 +2,566	+25%	+$46.2K	﹤0.01%	2367
2021 Q4	$220K	Sell	10,085 -114,278	-92%	-$2.25M	﹤0.01%	2446
2021 Q3	$2.29M	Buy	124,363 +35,478	+40%	+$714K	﹤0.01%	1439
2021 Q2	$1.9M	Buy	88,885 +23,459	+36%	+$477K	﹤0.01%	1533
2021 Q1	$1.26M	Buy	+65,426	New	+$1.15M	﹤0.01%	1659

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

SEI Investments's OCDX Position: Q2 2022 in Review

SEI Investments sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 12,651 shares — an estimated $249K sold.

SEI Investments first reported a position in OCDX in Q1 2021 and held it in 5 quarters. The position peaked at $2.29M in Q3 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

SEI Investments reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
SEI Investments sold 12,651 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $249K.
SEI Investments first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2021 and held it in 5 quarters.
SEI Investments's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $2.29M in Q3 2021.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on SEI Investments's 13F filing for Q2 2022, filed 15 Aug 2022.